BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27819762)

  • 21. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
    Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
    APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
    Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic features of succinate dehydrogenase-deficient gastrointestinal stromal tumor].
    Cheng Y; Zhang Z; Zhu H; Guo L; Cheng Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):153-8. PubMed ID: 26956958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma.
    Hoekstra AS; van den Ende B; Julià XP; van Breemen L; Scheurwater K; Tops CM; Malinoc A; Devilee P; Neumann HP; Bayley JP
    Clin Genet; 2017 Apr; 91(4):536-544. PubMed ID: 27485256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant bladder pheochromocytoma with SDHB genetic mutation.
    Maeda M; Funahashi Y; Katoh M; Fujita T; Tsuruta K; Gotoh M
    Aktuelle Urol; 2013 Sep; 44(5):381-2. PubMed ID: 23807799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant head and neck paragangliomas in SDHB mutation carriers.
    Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
    Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
    Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
    PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac paragangliomas: A case series with clinicopathologic features and succinate dehydrogenase B immunostaining.
    Alakeel F; Al Sannaa G; Ibarra-Cortez SH; Reardon MJ; Czerniak B; Chan EY; Ro J
    Ann Diagn Pathol; 2020 Apr; 45():151477. PubMed ID: 32062474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exploration in pitfalls in interpreting SDHB immunohistochemistry.
    Ding CC; Chan S; Mak J; Umetsu SE; Simko JP; Ruiz-Cordero R; Saunders T; Chan E
    Histopathology; 2022 Aug; 81(2):264-269. PubMed ID: 35546442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.